The Cannabist Company Holdings Inc. filings document material-event reporting for a British Columbia cannabis operator with OTCQB-quoted shares and no securities registered under Section 12(b) of the Exchange Act. Recent 8-K disclosures focus on material definitive agreements, capital-structure matters and noteholder forbearance arrangements tied to the company’s 9.25% senior secured notes and 9.00% senior secured convertible notes due 2028.
The filing record also covers governance and executive-transition disclosures, consulting arrangements, shareholder voting matters, operating and financial results, and cannabis regulatory risk topics. These records frame CBSTF’s public disclosures around its licensed U.S. cultivation, manufacturing and dispensary operations, retail brand, debt instruments and corporate governance.
The Cannabist Company Holdings Inc. completed the previously announced sale of substantially all assets related to its Delaware operations to Arboretum PermitCo LLC for total consideration of $16.5 million.
The consideration includes $14.025 million payable at closing, subject to working capital adjustments, and $2.475 million held in escrow for up to twelve months under specified release conditions. The company is operating under Companies’ Creditors Arrangement Act proceedings in Canada with related Chapter 15 relief in the U.S. Following the closing, the Audit Committee determined the company cannot continue SEC periodic reporting without unreasonable effort and expense, and it does not intend to file its Form 10-K for 2025 or any future Form 10-Qs.
The Cannabist Company Holdings Inc. reported that President Jesse Channon resigned his employment position effective April 1, 2026. Channon, who joined the company in 2019 and later became President, will continue supporting the business as a non-employee consultant under a new agreement.
Under this Consulting Engagement Agreement, he will receive $10,000 per month to provide corporate services from April 2, 2026 through July 3, 2026, with the term extendable or terminable pursuant to its terms. The agreement includes customary confidentiality provisions and is filed as Exhibit 10.1.
The Cannabist Company Holdings Inc. is filing Post-Effective Amendments to terminate and deregister two Form S-3 registration statements. The amendments remove from registration any unsold securities originally registered under Registration Nos. 333-275821 (up to an aggregate offering price of $250,000,000) and 333-278472 (84,426,229 common shares). The company states that the offerings are being terminated in connection with a Companies’ Creditors Arrangement Act proceeding in Ontario commenced on March 24, 2026 and related Chapter 15 petitions filed in Delaware on March 25, 2026. Upon effectiveness of these amendments, no securities will remain registered under the Registration Statements.
The Cannabist Company Holdings Inc. is terminating its Form S-3 registration statements and deregistering all unsold securities registered thereunder.
The registrations covered up to an aggregate offering price of $250,000,000 under Registration No. 333-275821 and 84,426,229 shares of common stock under Registration No. 333-278472. The deregistration follows the commencement of CCAA proceedings in Ontario and voluntary Chapter 15 petitions filed in the U.S.
The Cannabist Company Holdings Inc. is filing Post-Effective Amendments to terminate and deregister all unsold common shares under its Form S-1 registration statements, including 18,755,082 and 33,366,315 common shares, as of the effectiveness of these amendments. The company cites commencement of a Canadian CCAA proceeding on March 24, 2026 and related Chapter 15 filings in the United States on March 25, 2026 as the context for terminating the offerings.
The Cannabist Company Holdings Inc. is filing post-effective amendments to terminate two Form S-1 registration statements and deregister all unsold common shares registered thereunder.
The filing identifies Registration No. 333-265095 which originally registered 18,755,082 common shares and Registration No. 333-275061 which originally registered 33,366,315 common shares (including 11,122,105 issuable upon exercise of warrants). The deregistration follows commencement of a Canadian restructuring under the CCAA on March 24, 2026 and Chapter 15 petitions filed on March 25, 2026; as of the effectiveness of these amendments, no securities remain registered under those registration statements.